FDA Investigator Cassandra Overking
Cassandra Overking has inspections in 2 countries as of 26 May 2023. Cassandra Overking has collaborated with a combined 686 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
26 May 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Canada,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Angela K Shen,
Anissa M Cheung,
Ann Marie Montemurro,
Burnell M Henry,
CDR Jeremy L Wally, PhD,
Chad R Burger,
Christian D Lynch (CDL),
Christina D Lynch,
Cynthia Jim, CSO,
David S Cho, PhD,
Gene D Arcy,
J David Doleski,
Jacqueline Mdiaz Albertini,
James R Evans,
Joan A Loreng,
John D Finkbohner, PhD,
John M Mcinnis,
Laurie P Norwood,
LCDR Debra Emerson,
Lewis K Antwi,
Linda Thai,
Marion Michaelis,
Mark A Elengold,
Martha T Olone,
Mihaly S Ligmond,
Nicholas Obiri, PhD,
Omatunde O Osunsamni,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Robert W Jennings,
Robin Levis, PhD,
Rose Ashley,
Rose M Ashley,
Sean R Bryd,
Steven A Rubin,
Susan F Laska, MS,
Susan M Jackson,
Susan Yu
Cassandra Overking's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2014 | FDA 483 | ID Biomedical Corporation of Quebec d/b/a/ GSK - Form 483, 2014-04-09 |
March, 2011 | FDA 483 | Seqirus Vaccines Limited - Form 483, 2011-03-18 |
April, 2014 | FDA 483 | ID Biomedical Corporation of Quebec - Form 483, 2014-04-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more